Skip to search formSkip to main contentSkip to account menu

PF 04928473

Known as: PF-04928473, PF04928473 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

SNX 2112

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis
Purpose: Prostate cancer responds initially to antiandrogen therapies; however, progression to castration-resistant disease… 
2011
2011
CLU inhibition using OGX-011 as an adjuvant therapeutic strategy for HSP90 inhibition in prostate cancer.
4573 Background: Prostate cancer (PCa) responds initially to anti-androgen therapies, however, progression to castration… 
2010
2010
Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)